A Clinician's Perspective: Commentaries from the Journal of the American Academy of Dermatology

Conclusions

• Atopic dermatitis is not a significant risk factor for developing keratoconus, suggesting the need for regular ophthalmologic assessments in atopic patients regardless of this association.
• Ocular surface disease is a notable complication in atopic dermatitis patients treated with dupilumab, highlighting the importance of ophthalmological care to manage adverse effects.
• The identification of CARD14 mutations in patients with papulosquamous eruptions emphasizes the need for personalized biologic therapies based on genetic influences.
• The association of granuloma annulare with malignancies is rare, particularly in older patients, and only requires additional screening when clinical presentation suggests further risk.
• Dermatologists should exercise caution in diagnosing vascular lesions in patients with a history of radiation therapy due to the potential for atypical post-radiation vascular proliferation.
• Merkel cell carcinoma continues to increase in incidence, necessitating awareness of recent advances in diagnostic and treatment modalities for improved patient outcomes.
• Teledermatology has become an integrated part of dermatological practice, enhancing patient access to specialty care during and after the COVID-19 pandemic.
• The findings support that the benefits of mRNA COVID-19 vaccinations outweigh the potential risks for autoimmune diseases, further promoting vaccination in at-risk populations.
• Treatment with low-dose oral minoxidil has shown promising efficacy for alopecia without increased cancer risk, encouraging its use as a viable treatment option for hair loss.